Interpace Biosciences extends maturity of $7.5M in secured notes to October 31, 2021

INTERPACE BIOSCIENCES, INC.

Ampersand Note principal $4.5M, 1315 Capital Note $3.0M; total $7.5M in secured debt.
Maturity date extended one month from September 30, 2021 to October 31, 2021.
This is the fourth amendment to each note; terms otherwise unchanged.
Security agreement remains in full force and effect.
Noteholders are related parties holding convertible preferred shares (39% and 26% fully diluted combined).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.